Ultrasonography Course

Level One Certification Course for doctors on Transcranial Ultrasonography with Applications for Cancer, Autism, ME/CFS and Neurodegenerative Disease.

The diagnosis, follow-up and treatment of neurological diseases

On the 9th and 10th December 2013 at the Amwaj Rotani Hotel
Cost: US$ 5,000, limited to the first 10 applicants

Lecturers:
James Jeffrey Bradstreet1,2, and Marco Ruggiero3

1Newport Brain Research Laboratory, Newport Beach, CA, USA.
 2Brain Treatment Center, Newport Beach, CA, and Buford, GA, USA.
3Department of Experimental and Clinical Biomedical Sciences, University of Firenze, Italy.

Abstract

Cancer tumours can be eradicated in a few short weeks using ultrasound to accurately place GcMAF near tumours. The reduction in tumour size is recorded week by week with ultrasound, and the patient can be given prints of the scans of the reducing tumours.  When the tumours are gone, GcMAF then goes on to remove cancer from the human body, preventing further metastases.  GcMAF is part of the immune system, which remembers how to prevent the cancer from returning.

Autism, once a rare disorder, is now approaching epidemic proportions, and it is calculated that it affects more than 1% of the adult population. Early recognition appears to be of vital importance to improve the quality of patients’ health and there is the need to develop convenient imaging techniques that allow primary care providers to study those brain alterations associated with autism.

We recently developed an easily accessible method to study the brain cortex using transcranial ultrasonography. This technique was first applied to the diagnosis and treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), a complex syndrome that share neuropathological similarities with autism.

During the course we shall show that this technique can be used in autism and in other neurodegenerative diseases in order to study the brain alterations that have been described using magnetic resonance imaging. Our results demonstrate that transcranial ultrasonography is able to visualize some of the hallmarks of the autistic brain that are: reduction of gray matter, disorganization of the neuronal layers, excessive cerebrospinal fluid in the sub-arachnoid space.

We also demonstrate that, in addition to its role in diagnosis and follow-up, this technique can also prove useful in the management of some of the most disturbing symptoms of autism. This technique could prove useful to deliver neuroprotective compounds such as GcMAF to the particular areas of the brain that are involved in autism and other neurodegenerative diseases.


Programme

Day 1.

Morning.

1. Introduction to transcranial sonography in the early diagnosis, assessment of severity and follow-up. Lectures.

2. Transcranial sonography in the treatment of neurological conditions: state of the art and future applications. Lectures.

Lunch break.

Afternoon.

1. Practical demonstration on the use of transcranial sonography in diagnosis. Each teacher will demonstrate the use of the ultrasound system. Two advanced ultrasound system will be available.

2. Hands-on practice. Each teacher will assist each participant in obtaining the images required for diagnosis.

Day 2.

Morning.

1. Discussion of clinical cases. Clinical cases and images obtained by the teachers will be discussed and presented. Lectures.

2. Hands-on practice (continued). Each teacher will assist each participant in obtaining the images required for diagnosis.

Lunch break.

Afternoon.

1. Practice with patients brought in by participants. Each participant will be able to examine a patient of his with the supervision of the teachers.

2. Collegial discussion on clinical cases.

At the end of the course a certificate of participation and a certificate of proficiency will be awarded by the International Child Development Resource Center, USA